NEW YORK, Feb. 25, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Monolithic Power Systems, Inc. (“Monolithic” or the “Company”) (NASDAQ: MPWR). Such investors are advised to contact Danielle Peyton […]
NEW YORK, Feb. 25, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Intellia Therapeutics, Inc (“Intellia” or the “Company”) (NASDAQ :NTLA). Such investors are advised to contact Danielle Peyton […]
NEW YORK, Feb. 25, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Neumora Therapeutics, Inc. (“Neumora” or the “Company”) (NASDAQ: NMRA). Such investors are advised to contact Danielle Peyton […]
NEW YORK, Feb. 25, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Huntington Ingalls Industries, Inc. (“Huntington Ingalls” or the “Company”) (NASDAQ: HII). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, […]
NEW YORK, Feb. 25, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against GSK plc (“GSK” or the “Company”) (NYSE: GSK). Such investors are advised to contact Danielle Peyton at [email protected] or […]
